Demographic and clinical features
Treatment group
Control group
χ
2
P value
Sex
Male
13
13
0.00
1.00
Female
7
7
Age (years)
<65
14
6
0.00
1.00
≥ 65
14
6
Stage
IIIB
5
4
0.14
1.00
IV
15
16
KPS
60 ≤ KPS<80
8
5
1.03
0.50
80 ≤ KPS<100
12
15
Table 1:
Characteristics of lung cancer patients enrolled: There were no significant differences in demographic or clinical characteristics between the two groups (P<0.05).